32,601 reports of this reaction
12.1% of all Repatha reports
#1 most reported adverse reaction
DEVICE DIFFICULT TO USE is the #1 most commonly reported adverse reaction for Repatha, manufactured by Amgen USA Inc.. There are 32,601 FDA adverse event reports linking Repatha to DEVICE DIFFICULT TO USE. This represents approximately 12.1% of all 269,908 adverse event reports for this drug.
Patients taking Repatha who experience device difficult to use should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DEVICE DIFFICULT TO USE is a frequently reported adverse event for Repatha, accounting for a significant proportion of all reports.
In addition to device difficult to use, the following adverse reactions have been reported for Repatha:
The following drugs have also been linked to device difficult to use in FDA adverse event reports:
DEVICE DIFFICULT TO USE has been reported as an adverse event in 32,601 FDA reports for Repatha. This does not prove causation, but indicates an association observed in post-market surveillance data.
DEVICE DIFFICULT TO USE accounts for approximately 12.1% of all adverse event reports for Repatha, making it one of the most commonly reported side effect.
If you experience device difficult to use while taking Repatha, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.